Abstract
Sickle cell disease results in significant morbidity and mortality for those affected with this disease. Despite the fact that every case of sickle cell disease results from the same genetic mutation, there is considerable heterogeneity in the clinical course of the disease. Considerable knowledge has been gained regarding the complications of sickle cell disease including pain episodes, infections, stroke, and lung disease. Clarifying the clinical course of sickle cell disease has enabled us to develop therapies to decrease the morbidity of this disease and, with hope, will direct further investigations into novel treatment interventions.
Citations
Jul 12, 2002·Annals of Neurology·Mara PrenglerRobert J Adams
Oct 18, 2000·Pathology Oncology Research : POR·S A CohenM A Mascelli
Mar 17, 2007·Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence·Robert B NollAmy Short
Mar 21, 2002·Journal of Pediatric Hematology/oncology·E B FungV A Stallings
Aug 13, 2005·Journal of Pediatric Hematology/oncology·Tonya M PalermoBrian Berman
Jul 25, 2008·Echocardiography·Ana G AlmeidaJ Ducla-Soares
Feb 15, 2011·Pediatric Blood & Cancer·Sian CottonMeghan E McGrady
Mar 27, 2015·Pediatric Blood & Cancer·Titilope A AdeyemoAlani S Akanmu
May 1, 2001·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·E B FungV A Stallings
Jun 5, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Michael RothRosanna Ricafort
Jul 22, 2014·European Journal of Haematology·Inês Vaz SilvaAnabela Morais
Jan 7, 2004·Orthopaedic Nursing·Marjorie HammerH M Reynolds
Jun 1, 2005·Pediatric Blood & Cancer·Iris D BuchananGeorge W Reed
Oct 20, 2020·American Journal of Hematology·Richard OnaloClaudia R Morris
Feb 4, 2003·Pediatrics·Andreas J Deymann, Kenneth K Goertz